In our study, immuno-labeling for laminin-α2 in three patients showed nearly normal expression, consistent with literature reported that LGMD R23, the mild phenotype of LAMA2-MD is generally associated with partial reduction in laminin-α2 (2). The gene discussed is LAMA2; the disease is limb-girdle muscular dystrophy.